Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
EDSA Edesa Biotech Inc
- Stocks
- Healthcare
- NASDAQ: EDSA
Price (delayed)
$1.95
Market cap
$13.69M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.59
Enterprise value
-$202,428
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases with clear unmet medical needs. The company's two lead product candidates, EB05
Highlights
EDSA's debt has dropped by 100% year-on-year
Edesa Biotech's EPS has increased by 33% YoY and by 15% from the previous quarter
Key stats
What are the main financial stats of EDSA
Market
Valuations
Earnings
Shares outstanding
7.02M
Market cap
$13.69M
Enterprise value
-$202,428
Price to earnings (P/E)
N/A
Price to book (P/B)
0.87
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$6.47M
Net income
-$5.84M
EBIT
-$5.84M
EBITDA
-$5.67M
Free cash flow
-$5.72M
Per share
Balance sheet
Liquidity
EPS
-$1.59
EPS diluted
-$1.59
Free cash flow per share
-$1.08
Book value per share
$2.24
Revenue per share
$0
TBVPS
$2.72
Total assets
$16.45M
Total liabilities
$914,701
Debt
$0
Equity
$15.54M
Working capital
$13.47M
Debt to equity
0
Current ratio
15.73
Quick ratio
15.61
Net debt/EBITDA
2.45
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-78.7%
Return on equity
-103.1%
Return on invested capital
N/A
Return on capital employed
-37.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EDSA stock price
How has the Edesa Biotech stock price performed over time
Intraday
-2.01%
1 week
-2.01%
1 month
-18.21%
1 year
-57.52%
YTD
16.07%
QTD
-20.08%
Financial performance
How have Edesa Biotech's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$6.47M
Net income
-$5.84M
Gross margin
N/A
Net margin
N/A
Edesa Biotech's operating income has increased by 24% YoY and by 8% from the previous quarter
EDSA's net income is up by 19% year-on-year and by 4.4% since the previous quarter
Price vs fundamentals
How does EDSA's price correlate with its fundamentals
Growth
What is Edesa Biotech's growth rate over time
Valuation
What is Edesa Biotech stock price valuation
P/E
N/A
P/B
0.87
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Edesa Biotech's EPS has increased by 33% YoY and by 15% from the previous quarter
EDSA's price to book (P/B) is 79% lower than its 5-year quarterly average of 4.2 and 78% lower than its last 4 quarters average of 3.9
Efficiency
How efficient is Edesa Biotech business performance
The company's return on equity has surged by 52% QoQ and by 11% YoY
Edesa Biotech's return on assets has increased by 37% QoQ and by 11% YoY
Dividends
What is EDSA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EDSA.
Financial health
How did Edesa Biotech financials performed over time
Edesa Biotech's total assets has soared by 154% YoY
The total liabilities has dropped by 57% year-on-year and by 52% since the previous quarter
EDSA's debt is 100% smaller than its equity
EDSA's debt to equity has dropped by 100% year-on-year
EDSA's debt has dropped by 100% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.